Issels Integrative Immuno-Oncology December 10, 2015  

Blood Cancer May be Caused by Malaria Carrying Parasites

Dear Friend,

A promising new study, published August 2015 in the scientific journal, Cell, establishes a possible link between malaria carrying parasites and the development of blood cancer.

A Surprising Link Found

In the study, a group of scientists used mice to demonstrate how malaria-carrying parasites, such as mosquitoes, may lead to blood cancer. Although at present there is nothing to show that the same response may occur in humans, the results are promising as far as determining a surprising cause and effect between seemingly unrelated events that have confounded doctors for more than 50 years.

Prolonged Exposure is a Contributing Factor

Over a prolonged period of time, when a specific immune cell named B lymphocyte is exposed to the malaria infection, it develops cancer-causing faults within its make-up. Ultimately, a certain blood cancer called Burkitt's lymphoma presents.

P53 Plays a Key Part

Interestingly, the absence of a protein called P53 plays a key role in whether the immune cells mutate into cancer cells. The mice used in the aforementioned study were selected specifically because of the absence of the P53 gene.

More Research is Needed

More research is necessary before conclusive evidence will emerge regarding the relationship between prolonged exposure to malaria and Burkitt's lymphoma in humans. However, the clues uncovered in this study represent a giant step toward a cure for this devastating disease.

As more information becomes available to the scientific community regarding Burkitt's lymphoma causes and cures, you can rely on Issels® to bring it to you in an easy to understand, comprehensive fashion. Contact us today to learn more about our integrative immunotherapy treatments.

Too far to travel?

Read more interesting articles on the "Issels Integrative Immuno-Oncology" news/blog posted every Tuesday and Thursday. Check It Out Now »

Off-Label Arthritis Drug Shows Promise in Blood Cancer Treatment

A common drug used in the treatment of arthritis may offer a new hope for blood cancer patients. At one thousandth of the cost of today's latest blood cancer treatment, Issels® wanted to let you know about this important discovery. Methotrexate. A drug commonly used to treat inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis shows promise in treating blood cancer.

Get the Full Story!

Gene Therapy Shows 'Unprecedented Success' against Blood Cancers

Advanced genetically-targeted treatments are proving to be remarkably successful against leukemia and other blood cancers. Here's what the Associated Press had to say: "In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients' blood cells into soldiers that seek and destroy cancer."

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us